These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22895346)

  • 1. Uveal melanoma dormancy: an acceptable clinical endpoint?
    Blanco PL; Lim LA; Miyamoto C; Burnier MN
    Melanoma Res; 2012 Oct; 22(5):334-40. PubMed ID: 22895346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells in uveal melanoma.
    Torres V; Triozzi P; Eng C; Tubbs R; Schoenfiled L; Crabb JW; Saunthararajah Y; Singh AD
    Future Oncol; 2011 Jan; 7(1):101-9. PubMed ID: 21174541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
    Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
    Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
    Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S
    Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma.
    Kashyap S; Meel R; Singh L; Singh M
    Semin Diagn Pathol; 2016 May; 33(3):141-7. PubMed ID: 26972224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.
    Ulmer A; Beutel J; Süsskind D; Hilgers RD; Ziemssen F; Lüke M; Röcken M; Rohrbach M; Fierlbeck G; Bartz-Schmidt KU; Grisanti S
    Clin Cancer Res; 2008 Jul; 14(14):4469-74. PubMed ID: 18628461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selected prognostic factors of malignant uveal melanoma].
    Svetlosáková Z; Krásnik V; Gergisáková H; Babál P; Kusenda P
    Cesk Slov Oftalmol; 2012 Feb; 68(1):38-42. PubMed ID: 22679696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye.
    Bourla DH; Young TA
    Semin Ophthalmol; 2007; 22(3):175-7. PubMed ID: 17763240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines in uveal melanoma. Original title: uveal melanoma cytokines].
    Filer RS; Song JC; Char DH; Kaleta-Michaels S
    Klin Monbl Augenheilkd; 1993 Mar; 202(3):174-9. PubMed ID: 8510410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects.
    Baggetto LG; Gambrelle J; Dayan G; Labialle S; Barakat S; Michaud M; Grange JD; Gayet L
    Cancer Treat Rev; 2005 Aug; 31(5):361-79. PubMed ID: 15994016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Metastatic Uveal Melanoma: Progress and Challenges.
    Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
    BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic uveal melanoma.
    Singh AD; Borden EC
    Ophthalmol Clin North Am; 2005 Mar; 18(1):143-50, ix. PubMed ID: 15763199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pathological basis of the argument in the treatment of melanoma of the uveal tract].
    Li YP
    Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
    Shildkrot Y; Wilson MW
    Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ocular and metastatic uveal melanoma in an animal model.
    Blanco PL; Marshall JC; Antecka E; Callejo SA; Souza Filho JP; Saraiva V; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4376-82. PubMed ID: 16303923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.